Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Atherosclerosis
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Statins=== [[Statin]] medications are widely prescribed for treating atherosclerosis. They have shown benefit in reducing cardiovascular disease and mortality in those with [[high cholesterol]] with few side effects.<ref>{{cite journal | vauthors = Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S | title = Statins for the primary prevention of cardiovascular disease | journal = The Cochrane Database of Systematic Reviews | volume = 2013 | issue = 1 | pages = CD004816 | date = January 2013 | pmid = 23440795 | pmc = 6481400 | doi = 10.1002/14651858.CD004816.pub5 }}</ref> Secondary prevention therapy, which includes high-intensity statins and aspirin, is recommended by multi-society guidelines for all patients with a history of ASCVD (atherosclerotic cardiovascular disease) to prevent the recurrence of coronary artery disease, ischemic stroke, or peripheral arterial disease.<ref>{{cite journal | vauthors = Virani SS, Smith SC, Stone NJ, Grundy SM | title = Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia | journal = Circulation | volume = 141 | issue = 14 | pages = 1121β1123 | date = April 2020 | pmid = 32250694 | doi = 10.1161/CIRCULATIONAHA.119.044282 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J | title = 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines | journal = Journal of the American College of Cardiology | volume = 73 | issue = 24 | pages = e285βe350 | date = June 2019 | pmid = 30423393 | doi = 10.1016/j.jacc.2018.11.003 | hdl-access = free | hdl = 20.500.12749/1738 }}</ref> However, prescription of and adherence to these guideline-concordant therapies is lacking, particularly among young patients and women.<ref>{{cite journal | vauthors = Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PW, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM | title = Sex Differences in the Use of Statins in Community Practice | journal = Circulation. Cardiovascular Quality and Outcomes | volume = 12 | issue = 8 | pages = e005562 | date = August 2019 | pmid = 31416347 | pmc = 6903404 | doi = 10.1161/CIRCOUTCOMES.118.005562 }}</ref><ref>{{cite journal | vauthors = Lee MT, Mahtta D, Ramsey DJ, Liu J, Misra A, Nasir K, Samad Z, Itchhaporia D, Khan SU, Schofield RS, Ballantyne CM, Petersen LA, Virani SS | title = Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease | journal = JAMA Cardiology | volume = 6 | issue = 7 | pages = 782β790 | date = July 2021 | pmid = 33881448 | pmc = 8060887 | doi = 10.1001/jamacardio.2021.0683 }}</ref> [[Statin]]s work by inhibiting HMG-CoA (hydroxymethylglutaryl-coenzyme A) reductase, a hepatic rate-limiting enzyme in cholesterol's biochemical production pathway. Inhibiting this rate-limiting enzyme reduces the body's ability to produce as much cholesterol endogenously, thereby reducing the level of LDL-cholesterol in the blood. This reduced endogenous cholesterol production triggers the body to then pull cholesterol from other cellular sources, enhancing serum HDL-cholesterol.{{citation needed|date=January 2021}} These data are primarily in middle-aged men and the conclusions are less clear for women and people over the age of 70.<ref>{{cite journal | vauthors = Vos E, Rose CP | title = Questioning the benefits of statins | journal = CMAJ | volume = 173 | issue = 10 | pages = 1207; author reply 1210 | date = November 2005 | pmid = 16275976 | pmc = 1277053 | doi = 10.1503/cmaj.1050120 }}</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Atherosclerosis
(section)
Add topic